Enovis

Enovis

Health Care Equipment & Supplies
Enovis Corp is a medical technology company that offers medical devices and services across the continuum of patient care, from injury prevention to joint replacement to rehabilitation after surgery, injury, or degenerative disease. Its reportable segments are Prevention & Recovery (P&R) and Reconstructive (Recon). The company generates the maximum revenue from the Prevention & Recovery segment, which includes products that are used to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformities, traumatic events, and sports-related injuries. The Reconstructive segment provides a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and surgical productivity tools. Geographically, it derives key revenue from the U.S.

$1.7B

Market Cap • 11/5/2026

1998

(28 years)

Founded

2008

(18 years ago)

IPO

NYSE

Listing Exchange

Flag of United States

United States

Country

Valuation

P/B

1,1

P/S

0,7

P/EBITDA

—

P/OCF

6,4

P/FCF

23,7

P/E

—

BVPS

25,9

EPS

—

Market Cap

Market Cap

1,7B

EV

3B

EV/Revenue

1,3

EV/EBITDA

-16,4

EV/EBIT

-6,2

Payout

Dividend Per Share

0

Dividend Yield

0%

Buyback Yield

0%

Total Yield

0%

Payout

0%

Retained Earnings

-1,5B

Profitability

Gross Margin

61,3%

EBITDA Margin

—

EBIT Margin

—

Net Margin

—

D&A/EBITDA

0%

R&D/Revenue

5,5%

Capex/Revenue

8,2%

Capex/D&A

64,2%

Capex/OCF

73,1%

SBC/OCF

13%

% PPE

16,1%

% Goodwill

18,8%

ROE

—

ROIC

—

Growth

CAGR Revenue 5Y

-1%

CAGR OCF 5Y

-7,8%

Leverage

N.D./EBITDA

—

Debt/Equity

0%

Current Ratio

2,2

Quick Ratio

0,8

Interest Coverage

—

Premium

Unlock 100% of the data and have immediate access on more than 6.000 companies with updated information!
  • Unrestricted access
  • Unlimited data history
  • Analysis videos
  • Quarterly highlights
  • Customizable financials table
  • Ranking
  • Discussions

...and much more!

Get Premium